Sabra Health Care REIT: Barclays cuts target price to $21 from $23
SBRA•Barclays cut its target price for Sabra Health Care REIT to $21 from $23.
Related News
Goosehead Insurance target price cut to $48 from $58 by Truist Securities
GSHD•
Orbital Infrastructure Group: Raymond James initiates coverage with market perform rating
OIG•
Dolphin Entertainment CEO William O'Dowd IV buys $4,784 of common shares
DLPN•
IQVIA expands partnership with Veeva, selects its clinical operations apps as enterprise standard
IQV•
Alkermes to present Phase 3 REVITALYZ trial results for LUMRYZ in idiopathic hypersomnia at Sleep Europe 2026
ALKS•